Purchase Order HHSN268201200108P

<p>The National Heart Lung and Blood Institute awarded a purchase order to Sequenom, Inc. for $37,800 on May 1, 2011, for maintenance and repair of instruments and laboratory equipment. Work is performed in Bethesda, Maryland. The order carries a firm fixed price and an ultimate completion date of April 30, 2012.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Illumina, Inc. for an MiSeq 2 sequencer assembly (catalog 15033616) valued at $95,931.00 on September 26, 2017, with completion by October 26, 2017. Performance occurs at Bethesda, Maryland 20892. The order is a firm fixed-price acquisition of this proprietary genomic sequencing instrument, no set-aside designation applied.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Illumina, Inc. for $68,310.00 on September 16, 2012, to provide critical function and service maintenance for a HiSeq 2000 instrument in the NISC Lab. Work is performed in Bethesda, Maryland. The order carries firm fixed price terms and an ultimate completion date of September 15, 2013. No set-aside was applied.</p>

<p>The National Heart Lung and Blood Institute issued a $38,844 delivery order to Illumina, Inc. on November 4, 2014, for genetic sequencing and genomic analysis equipment and materials, with an ultimate completion date of August 31, 2015.</p> <p>Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation. The source does not identify the parent vehicle under which this delivery order was issued.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Illumina, Inc. for $45,726.00 on June 23, 2011, with an ultimate completion date of August 12, 2012. The order covers maintenance and repair of instruments and laboratory equipment. Performance takes place in Bethesda, Maryland. Pricing is firm fixed price with no set-aside category applied.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Illumina, Inc. for $35,650 on November 9, 2012, for critical function and LIHA service contract to maintain scientific equipment used for clinical research. Performance is in Bethesda, Maryland. The order was scheduled for ultimate completion on November 8, 2013. Pricing is firm fixed price.</p>

<p>The National Heart Lung and Blood Institute issued a $33,291 delivery order to Illumina, Inc. on September 4, 2014, for genetic sequencing reagents and consumables supporting genomic research.</p> <p>Place of performance is Bethesda, Maryland. The order carries a firm fixed-price structure with an ultimate completion date of August 31, 2015. No set-aside was applied.</p>

<p>The National Heart Lung and Blood Institute issued a $12,181 delivery order to Illumina, Inc. on September 19, 2014, for firm fixed-price procurement of genetic sequencing equipment and reagents.</p> <p>Place of performance is Bethesda, MD. The order has an ultimate completion date of August 31, 2015. No set-aside was used.</p>

<p>The National Heart Lung and Blood Institute issued a $23,099 delivery order to Illumina, Inc. on November 18, 2014, for genetic sequencing equipment and related supplies, with performance at Bethesda, MD and completion by August 31, 2015.</p> <p>The order is firm fixed price with no set-aside designation.</p>

<p>The National Heart Lung and Blood Institute issued a $108,771 delivery order to Illumina, Inc. on December 19, 2014, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD. The order is firm fixed price with an ultimate completion date of August 31, 2015. The source does not identify the parent IDIQ or GWAC vehicle under which this delivery order was issued.</p>